Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Parkinson's Disease at an early to middle stage (stages 1 to 3 on a standard scale used by doctors)
- You are able to walk 50 metres (roughly the length of half a football pitch) on your own without help
- You are able to understand and have a conversation in English
- You have scored above 18 on a memory and thinking test called the MoCA, which means your thinking and memory are mostly intact (confirm with trial site)
Who may not be able to join:
- You have a heart condition or another condition affecting your muscles or nerves that is not well controlled and would stop you from taking part in a physical training programme
- You have an ongoing condition where your immune system attacks your body, such as rheumatoid arthritis, or another serious illness that could affect your participation
- You have an injury or have had surgery on your arms or legs that has not fully healed and would stop you from doing weight-based exercise
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Joseph F. Signorile, PhD, University of Miami
Phone: 3052844173
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in neuromuscular performance as measured by 1-repetition maximum (1RM); Change in neuromuscular performance as measured by Power Production
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.